Corrected: SiTime Q2 revenue jumps 127% on CED segment growth
CORRECTED-SiTime Q2 revenue jumps 127% on CED segment growth Corrects EPS figure from $0.69 to $0.66 in KD table
Overview
Precision timing chipmaker's Q2 revenue rose 127% yr/yr, beating analyst expectations
Adjusted EPS for Q2 was $2.34; net income turned positive yr/yr
On July 1, company completed Renesas Timing Business acquisition, expanding product portfolio
Outlook
Company did not provide specific guidance in the press release
Result Drivers
SEGMENT GROWTH - Co said every segment grew by at least 50%, with CED segment up 181%
GROSS MARGIN IMPROVEMENT - Co reported non-GAAP gross margin of 67.1%, up from 58.2% a year ago
Company press release: ID:nGNX7pLWDp
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $157.43 mln | $146.38 mln (8 Analysts) |
Q2 EPS |
| $0.66 |
|
Q2 Net Income |
| $18.16 mln |
|
Q2 Gross Profit |
| $99.14 mln |
|
Q2 Operating Income |
| $8.22 mln |
|
Q2 Pretax Profit |
| $18.20 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the semiconductors peer group is "buy"
Wall Street's median 12-month price target for SiTime Corporation is $847.21, about 45.3% above its August 4 closing price of $583.06
The stock recently traded at 60 times the next 12-month earnings vs. a P/E of 99 three months ago
Reuters Recommended Reads
Aug 4 - Astera Labs Q2 revenue more than doubles, beats estimates
Aug 4 - Lattice Semiconductor Q2 profit beats estimates on AI-related server demand
Aug 5 - Netlist, Samsung settle patent disputes in new five-year memory deal
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on SiTime
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Benchmark initiates SiTime at 'buy,' calling it a timing market disruptor; shares rise
U.S. STOCKS ON THE MOVE-Braveheart Bio, Paysign, Hertz Global
U.S. STOCKS ON THE MOVE-Ralph Lauren, Sempra, Parker-Hannifin, Lincoln International
U.S. STOCKS ON THE MOVE- MACOM Technology , Becton Dickinson, Centrus Energy